Covalent Molecular Probes for Class A G Protein-Coupled Receptors: Advances and Applications

被引:50
|
作者
Weichert, Dietmar [1 ]
Gmeiner, Peter [1 ]
机构
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, Med Chem, D-91052 Erlangen, Germany
关键词
MU-OPIOID RECEPTOR; AFFINITY ACYLATING ANTAGONISTS; CRYSTAL-STRUCTURE; BINDING-SITE; PHARMACOLOGICAL CHARACTERIZATION; IRREVERSIBLE LIGANDS; ACETYLCHOLINE MUSTARD; MUSCARINIC RECEPTORS; ADENOSINE RECEPTOR; MEDIATED PHENOMENA;
D O I
10.1021/acschembio.5b00070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Covalent modification of G. protein-coupled receptors (GPCRs) by employing specific molecular probes has for decades provided a successful strategy to facilitate the elucidation of the structure and function of this pharmacologically important class of membrane proteins. The ligands typically comprise a pharmacophore that generates affinity for a given GPCR and contain a reactive functionality that may form, a covalent bond With a suitably positioned amino acid residue. Covalent ligands have been successfully applied to circumvent poor affinity of compounds when stable labeling of receptor populations was required, and they have been used in the isolation, purification, and pharmacological characterization of specific subtypes of GPCRs. Recently, structural studies have demonstrated that Covalent molecular probes are effective at stabilizing GPCRs to obtain X-ray crystal structures, thus providing valuable insights for the development of novel therapeutics. Herein, we review covalently binding molecular probes for class A GPCRs with a focus on ligands comprising cross-linking groups that do not require photo activation and further highlight their significant and diverse applications.
引用
收藏
页码:1376 / 1386
页数:11
相关论文
共 50 条
  • [1] Covalent functionalization of G protein-coupled receptors by small molecular probes
    Beerkens, Bert L. H.
    Ijzerman, Adriaan P.
    Heitman, Laura H.
    van der Es, Daan
    RSC CHEMICAL BIOLOGY, 2025,
  • [2] Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors
    Bartuzi, Damian
    Kaczor, Agnieszka A.
    Targowska-Duda, Katarzyna M.
    Matosiuk, Dariusz
    MOLECULES, 2017, 22 (02)
  • [3] Applications of molecular replacement to G protein-coupled receptors
    Kruse, Andrew C.
    Manglik, Aashish
    Kobilka, Brian K.
    Weis, William I.
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2013, 69 : 2287 - 2292
  • [4] G protein-coupled receptors - recent advances
    Latek, Dorota
    Modzelewska, Anna
    Trzaskowski, Bartosz
    Palczewski, Krzysztof
    Filipek, Slawomir
    ACTA BIOCHIMICA POLONICA, 2012, 59 (04) : 515 - 529
  • [5] Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
    Naganathan, Saranga
    Grunbeck, Amy
    Tian, He
    Huber, Thomas
    Sakmar, Thomas P.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (79):
  • [6] Molecular pharmacology of class II G protein-coupled receptors - Introduction
    Sexton, PM
    RECEPTORS & CHANNELS, 2002, 8 (3-4): : 135 - 136
  • [7] Advances in the molecular understanding of G protein-coupled receptors and their future therapeutic opportunities
    Obot, Daniel N.
    Udom, Godswill J.
    Udoh, Anwanabasi E.
    Onyeukwu, Nkechi J.
    Olusola, Ayobami J.
    Udoh, Ikanke M.
    Umana, Israel K.
    Yemitan, Omoniyi K.
    Okokon, Jude E.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [8] Advances in the molecular understanding of G protein-coupled receptors and their future therapeutic opportunities
    Daniel N. Obot
    Godswill J. Udom
    Anwanabasi E. Udoh
    Nkechi J. Onyeukwu
    Ayobami J. Olusola
    Ikanke M. Udoh
    Israel K. Umana
    Omoniyi K. Yemitan
    Jude E. Okokon
    Future Journal of Pharmaceutical Sciences, 7
  • [9] Molecular architecture of G protein-coupled receptors
    vanRhee, AM
    Jacobson, KA
    DRUG DEVELOPMENT RESEARCH, 1996, 37 (01) : 1 - 38
  • [10] Molecular pharmacology of G protein-coupled receptors
    Summers, R. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (20) : 2931 - 2933